Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

435 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
Sculier JP, Paesmans M, Thiriaux J, Lecomte J, Bureau G, Giner V, Efremidis A, Lafitte JJ, Berchier MC, Alexopoulos CG, Zacharias C, Mommen P, Ninane V, Klastersky J. Sculier JP, et al. J Clin Oncol. 1998 Apr;16(4):1388-96. doi: 10.1200/JCO.1998.16.4.1388. J Clin Oncol. 1998. PMID: 9552042 Clinical Trial.
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party.
Sculier JP, Paesmans M, Ninane V, Giner V, Bureau G, Lafitte JJ, Baumöhl J, Thiriaux J, van Cutsem O, Recloux P, Berchier MC, Zacharias C, Mommen P, van Houtte P, Klastersky J. Sculier JP, et al. Lung Cancer. 1998 Dec;22(3):201-13. doi: 10.1016/s0169-5002(98)00089-0. Lung Cancer. 1998. PMID: 10048473
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party.
Sculier JP, Paesmans M, Lafitte JJ, Baumöhl J, Thiriaux J, van Cutsem O, Recloux P, Bureau G, Berchier MC, Zacharias C, Mommen P, Bosschaerts T, Berghmans T, van Houtte P, Ninane V, Klastersky J. Sculier JP, et al. Ann Oncol. 1999 Mar;10(3):295-303. doi: 10.1023/a:1008319506107. Ann Oncol. 1999. PMID: 10355573 Free article. Clinical Trial.
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working Party.
Sculier JP, Paesmans M, Thiriaux J, Lecomte J, Bureau G, Giner V, Koumakis G, Lafitte JJ, Berchier MC, Alexopoulos CG, Zacharias C, Mommen P, Ninane V, Klastersky J. Sculier JP, et al. Eur J Cancer. 1999 Sep;35(9):1314-9. doi: 10.1016/s0959-8049(99)00029-5. Eur J Cancer. 1999. PMID: 10658520 Clinical Trial.
A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis.
Mascaux C, Paesmans M, Berghmans T, Branle F, Lafitte JJ, Lemaitre F, Meert AP, Vermylen P, Sculier JP; European Lung Cancer Working Party (ELCWP). Mascaux C, et al. Among authors: sculier jp. Lung Cancer. 2000 Oct;30(1):23-36. doi: 10.1016/s0169-5002(00)00127-6. Lung Cancer. 2000. PMID: 11008007 Review.
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
Sculier JP, Lafitte JJ, Paesmans M, Thiriaux J, Alexopoulos CG, Baumöhl J, Schmerber J, Koumakis G, Florin MC, Zacharias C, Berghmans T, Mommen P, Ninane V, Klastersky J. Sculier JP, et al. Br J Cancer. 2000 Nov;83(9):1128-35. doi: 10.1054/bjoc.2000.1413. Br J Cancer. 2000. PMID: 11027424 Free PMC article. Clinical Trial.
435 results